Abbott Laboratories
0
0
0%

Statistics

Valuation metrics
Market cap
233.12B
Enterprise value
238.23B
Trailing P/E (ttm)
16.81
Forward P/E
PEG ratio
Price/Sales (ttm)
5.32
Price/Book (mrq)
4.57
Enterprise Value/Revenue
5.43
Enterprise Value/EBITDA
20.28
Overview
Shares outstanding
1.74B
Float
1.73B
Shares short
% Held by insiders
0.54%
% Held by institutions
81.41%
Average volume (10 days)
40
Average volume (90 days)
13
Price summary
52-Week low
112.41
52-Week high
135.90
52-Week change
15.99
Beta
0.71
50-Day moving average
133.81
200-Day moving average
118.40
Dividends and splits
Forward annual dividend rate
2.36
Forward annual dividend yield
0.02
Trailing annual dividend rate
2.36
Trailing annual dividend yield
0.02
5-Year annual dividend yield
Payout ratio
0.29
Dividend date
Ex-dividend date
Oct 15, 2025
Last split factor
Last split date
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
31.88%
Operating margin
19.40%
Operational effectiveness
Return on assets
6.79%
Return on equity
30.62%
Income statement
Revenue (ttm)
43.84B
Revenue per share (ttm)
25.19
Quarterly revenue growth (yoy)
6.90%
Gross profit (ttm)
24.67B
EBITDA
11.73B
Net income to common (ttm)
13.93B
Diluted EPS (ttm)
7.96
Quarterly earnings growth (yoy)
-0.10%
Balance sheet
Total cash (mrq)
7.73B
Total cash per share (mrq)
4.45
Total debt (mrq)
12.97B
Total Debt/Equity (mrq)
25.31
Current ratio (mrq)
170.30%
Book value per share (mrq)
29.30
Cash flow
Cash flow statement
9.12B
Levered free cash flow (LFCF)
6.07B
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 14 hours 25 minutes

19:04
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Main market
09:30 - 16:00
All times are displayed in the America/Santiago timezone (-03, UTC-03:00).